|
|
Developmental Disabilities Administration
|
September 9, 2022
|
|
|
New COVID-19 Booster for Ages 12 and Older
The U.S. Food and Drug Administration has approved the use of a new COVID-19 vaccine booster for people ages 12 and older. It’s called a “bivalant” booster, and it replaces the original booster for this age group.
If you are age 12 or older and have had the initial vaccination, you can choose one of these two booster options:
- Pfizer-BioNTech Bivalent booster
- Moderna Bivalant booster
What does this mean?
If you are age 12 or older, the current Moderna and Pfizer monovalent booster is no longer approved for your use.
Check with your local pharmacy or vaccination site for availability of the new booster. If you already have an appointment, you must reschedule for a time the new booster is available.
Why is this happening?
The bivalent booster helps protect against new variants. At this point, the FDA has only approved its use for persons age 12 and older. They can still be used as initial vaccinations and as boosters for children ages 5 to 11.
Read the FDA news release to learn more: Coronavirus (COVID-19) Update: FDA Authorizes Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose
|
|
|
|
